Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients

Experimental and Clinical Transplantation

Volumn 11, Issue 3, 2013, Pages 222-228

  Khanmoradi, Kamran ^a   Knorr, John P ^a   Feyssa, Eyob L ^a   Parsikia, Afshin ^a   Jawa, Pankaj ^a   Dinh, Duy Bao ^a   Campos, Stalin ^a   Zaki, Radi F ^a   Ortiz, Jorge A ^a  

^a EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Elderly; Induction therapy; Kidney transplant; Rabbit antithymocyte globulin; rATG

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; AGE; AGED; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERIATRIC PATIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; THROMBOCYTOPENIA;

ADULT; AGE FACTORS; AGED; ANIMALS; ANTILYMPHOCYTE SERUM; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PATIENT SELECTION; PHILADELPHIA; PREDNISONE; PROPORTIONAL HAZARDS MODELS; RABBITS; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880070494     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2012.0211     Document Type: Article

References (32)

1. Sener A, Schweitzer EJ, Munivenkatappa R, et al. Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation. 2009;87(10):1549-1554.
2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.
3. Ghafari A, Ardalan MR. Renal transplantation in elderly recipients: a single-center experience. Transplant Proc. 2008;40(1):238-239.
4. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation. 2007;83(8):1069-1074.
5. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol. 2006;1(3):532-538.
6. Macrae J, Friedman AL, Friedman EA, Eggers P. Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States. Int Urol Nephrol. 2005;37(3):641-648.
7. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041-1050.
8. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev. 1999;108(1):1-7.
9. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine. 2007;25(16):3066-3069.
10. Hirokawa K. Understanding the mechanism of the age-related decline in immune function. Nutr Rev. 1992;50(12):361-366.
11. Friedman AL, Goker O, Kalish MA, et al. Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection. Int Urol Nephrol. 2004;36(3):451-456.
12. Taber DJ, Weimert NA, Henderson F, et al. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008;40(10):3401-3407.
13. Cai J, Terasaki PI. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation. 2010;90(12):1511-1515.
14. Shah T, Bunnapradist S, Hutchinson I, et al. The evolving notion of "senior" kidney transplant recipients. Clin Transplant. 2008;22(6):794-802.
15. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713-723.
16. Gill J, Sampaio M, Gill JS, et al. Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol. 2011;6(5):1168-1178.
17. Kasiske BL. The influence of donor age on renal function in transplant recipients. Am J Kidney Dis. 1988;11(3):248-253.
18. Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K. Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol. 2005;16(9):2557-2564.
19. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant. 2005;5(7):1681-1688.
20. Sung RS, Christensen LL, Leichtman AB, et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant. 2008;8(4):783-792.
21. Gill J, Cho YW, Danovitch GM, et al. Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database. Transplantation. 2008;85(1):62-68.
22. Remuzzi G, Grinyò J, Ruggenenti P, et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol. 1999;10(12):2591-2598.
23. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006;354(4):343-352.
24. Clesca P, Dirlando M, Park SI, et al. Thymoglobulin and rate of infectious complications after transplantation. Transplant Proc. 2007;39(2):463-464.
25. Patel SJ, Knight RJ, Suki WN, et al. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant. 2011;25(3):E250-E256.
26. Laftavi MR, Patel S, Soliman MR, et al. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011;43(2):466-468.
27. Mangray M, Vella JP. Hypertension after kidney transplant. Am J Kidney Dis. 2011;57(2):331-341.
28. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43(6):1071-1081.
29. Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol. 2004;15(1):187-193.
30. Joseph JT, Jindal RM. Influence of dialysis on post-transplant events. Clin Transplant. 2002;16(1):18-23.
31. Ushigome H, Sakai K, Suzuki T, et al. Kidney transplantation for patients on long-term hemodialysis. Transplant Proc. 2008;40(7):2297-2298.
32. Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation. 2009;87(12):1864-1869.